PhRMA Attacks Medicaid Proposal To Undermine Copay Coupons

By John Wilkerson / July 22, 2020 at 3:23 PM
Drug makers oppose a CMS proposal to undermine co-pay coupons by subtracting the value of those coupons from the prices companies charge Medicaid. The Pharmaceutical Research and Manufacturers of America also says CMS overstepped its legal authority by proposing a new definition of “line extension” that would make drug companies pay additional rebates when they find new uses for existing drugs, combine drugs or create new ways to administer them. The policies are part of a rule CMS proposed to...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.